# US 2021/0060348 A1 · Cardiac resynchronization therapy mode switching using mechanical activity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0060348 A1
- Document ID: US20210060348A1
- Status: Published application
- Kind: A1
- Application number: 17/001,627
- Filed: 2020-08-24
- Published: 2021-03-04
- Earliest claimed: 2019-08-28
- Assignees: Medtronic, Inc.
- Applicants: Medtronic, Inc.
- Inventors: Subham Ghosh
- Web page: https://patentgrep.com/patent/US20210060348A1

## CPC

- A61N 1/3624: {occurring in the atrium, i.e. atrial tachycardia}
- A61N 1/395: {for treating atrial fibrillation}
- A61N 1/36542: {controlled by body motion, e.g. acceleration}
- A61N 1/36578: {controlled by mechanical motion of the heart wall, e.g. measured by an accelerometer or microphone}
- A61N 1/36842: {Multi-site stimulation in the same chamber}
- A61N 1/36843: {Bi-ventricular stimulation}
- A61N 1/3688: {configured for switching the pacing mode, e.g. from AAI to DDD}
- A61N 1/3756: {Casings with electrodes thereon, e.g. leadless stimulators}
- A61N 1/39622: {Pacing therapy}
- A61N 1/056: {Transvascular endocardial electrode systems}
- A61N 1/3622: {comprising two or more electrodes co-operating with different heart regions}
- A61N 1/36507: {controlled by gradient or slope of the heart potential}
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

A method includes determining whether electrical activity is indicative of atrial fibrillation, determining whether mechanical activity is indicative of atrial fibrillation, and adjusting a pacing parameter or mode based on whether the electrical activity and the mechanical activity are indicative of atrial fibrillation. The electrical activity may be detected based on a far-field measurement. The method may be performed using a leadless implantable medical device.

## Claims

### Claim 1

An implantable medical system comprising:
a first electrode to sense electrical activity of one or both ventricles of a patient's heart or to deliver cardiac therapy to one or both ventricles of the patient's heart;
a second electrode to sense electrical activity of one or both atria of the patient's heart;
a motion sensor to sense mechanical activity of the patient's heart; and
a controller operably coupled to the first electrode, second electrode, and the motion sensor, the controller configured to:
switch between a dual-chamber sensing mode to deliver pacing based on sensing electrical activity of at least one atrium and at least one ventricle of the patient's heart and a single-chamber sensing mode to deliver pacing based on sensing electrical activity of only one or both ventricles of the patient's heart;
deliver pacing to at least one of the ventricles of the patient's heart using the first electrode in the dual-chamber sensing mode;
determine whether the electrical activity of one or both atria sensed by the second electrode is indicative of atrial fibrillation;
in response to determining that the electrical activity of one or both atria is indicative of atrial fibrillation, determine whether mechanical activity of the patient's heart sensed by the motion sensor represents atrial contraction; and
in response to determining that the mechanical activity of the patient's heart does not represent the atrial contraction, deliver inhibited pacing using the first electrode in the single-chamber sensing mode.

### Claim 2 (depends on 1)

The system of claim 1, wherein the electrical activity of one or both atria of the patient's heart is based on a far-field measurement sensed by the second electrode.

### Claim 3 (depends on 1)

The system of claim 1, wherein the first electrode and the second electrode are coupled to a leadless implantable medical device (IMD), wherein:
a housing of the leadless IMD is implantable in the right atrium (RA) of the patient's heart; and
the first electrode is implantable from the triangle of Koch region of the RA of the patient's heart to deliver cardiac therapy to or sense electrical activity of the left ventricle (LV) in the basal region, septal region, or basal-septal region of the left ventricular myocardium of the patient's heart.

### Claim 4 (depends on 1)

The system of claim 1, wherein the electrical activity of one or both atria of the patient's heart is based on a near-field measurement sensed by the second electrode.

### Claim 5 (depends on 1)

The system of claim 1, wherein to determine whether the electrical activity of one or both atria sensed by the second electrode is indicative of atrial fibrillation, the controller is further configured to determine whether a P-wave is detected.

### Claim 6 (depends on 5)

The system of claim 5, wherein, in response to determining that the mechanical activity of the patient's heart represents the atrial contraction, the controller is further configured to:
adjust an atrial activation threshold to detect the P-wave or adjust P-wave detection blanking periods; and
continue delivering pacing to at least one of the ventricles of the patient's heart in the dual-chamber sensing mode.

### Claim 7 (depends on 1)

The system of claim 1, wherein, in response to determining that the electrical activity of one or both atria is not indicative of atrial fibrillation, the controller is further configured to continue delivering pacing to at least one of the ventricles of the patient's heart in the dual-chamber sensing mode.

### Claim 8 (depends on 1)

The system of claim 1, wherein the mechanical activity of the patient's heart sensed by the motion sensor includes mechanical activity corresponding to an S4 heart sound.

### Claim 9 (depends on 1)

The system of claim 1, wherein to determine whether mechanical activity of the patient's heart sensed by the motion sensor represents the atrial contraction, the controller is further configured to detect an intrinsic ventricular activation of the patient's heart.

### Claim 10 (depends on 9)

The system of claim 9, wherein to determine whether mechanical activity of the patient's heart sensed by the motion sensor represents the atrial contraction, the controller is further configured to use mechanical activity in a time window that starts earlier than the intrinsic ventricular activation.

### Claim 11 (depends on 1)

The system of claim 1, wherein to determine whether mechanical activity of the patient's heart sensed by the motion sensor represents the atrial contraction, the controller is further configured to determine whether the mechanical activity exceeds a threshold value.

### Claim 12 (depends on 11)

The system of claim 11, wherein the controller is further configured to determine that the mechanical activity represents the atrial contraction in response to the mechanical activity exceeding the threshold value.

### Claim 13 (depends on 1)

The system of claim 1, wherein, after delivering inhibited pacing to at least one of the ventricles of the patient's heart in the single-chamber sensing mode, the controller is further configured to return to delivering pacing to at least one of the ventricles of the patient's heart in the dual-chamber sensing mode in response to determining that the electrical activity of one or both atria is not indicative of atrial fibrillation or determining that the mechanical activity of the patient's heart is indicative of the atrial contraction.

### Claim 14 (depends on 13)

The system of claim 13, wherein determining that the electrical activity of one or both atria is not indicative of atrial fibrillation comprises detecting a P-wave in the electrical activity of one or both atria, and wherein determining that the mechanical activity of the patient's heart represents the atrial contraction comprises determining that the mechanical activity exceeds a threshold value.

### Claim 15

A method comprising:
delivering pacing to at least one of the ventricles of a patient's heart in a dual-chamber sensing mode to deliver pacing based on sensing electrical activity of at least one atrium and at least one ventricle of the patient's heart;
determining whether electrical activity of one or both atria of the patient's heart is indicative of atrial fibrillation;
in response to determining that the electrical activity of one or both atria is indicative of atrial fibrillation, determining whether mechanical activity of the patient's heart represents an atrial contraction; and
in response to determining that the mechanical activity of the patient's heart does not represent the atrial contraction, delivering inhibited pacing to at least one of the ventricles of the patient's heart in a single-chamber sensing mode to deliver pacing based on sensing electrical activity of only one or both ventricles of the patient's heart.

### Claim 16 (depends on 15)

The method of claim 15, wherein the electrical activity of one or both atria of the patient's heart is based on a far-field measurement.

### Claim 17 (depends on 15)

The method of claim 15, wherein determining whether the electrical activity of one or both atria is indicative of atrial fibrillation comprises determining whether a P-wave is detected.

### Claim 18 (depends on 15)

The method of claim 15, wherein the mechanical activity of the patient's heart includes mechanical activity corresponding to an S4 heart sound.

### Claim 19

An implantable medical system comprising:
a first medical device comprising a housing implantable in at least one of the ventricles of a patient's heart, the first medical device further comprising:
at least one electrode to sense electrical activity of at least one of the ventricles or to deliver cardiac therapy to at least one of the ventricles of the patient's heart; and
at least one motion sensor to sense mechanical activity of the patient's heart;
a second medical device in operative communication with the first medical device comprising at least one electrode to sense electrical activity of one or both atria of the patient's heart; and
a controller configured to:
switch between a dual-chamber sensing mode to deliver pacing based on sensing electrical activity of at least one atrium and at least one ventricle of the patient's heart and a single-chamber sensing mode to deliver pacing based on sensing electrical activity of only one or both ventricles of the patient's heart;
deliver pacing to at least one of the ventricles of the patient's heart in the dual-chamber sensing mode;
determine whether the electrical activity of one or both atria sensed by the second medical device is indicative of atrial fibrillation;
in response to determining that the electrical activity of one or both atria is indicative of atrial fibrillation, determine whether mechanical activity of the patient's heart sensed by the first medical device represents the atrial contraction; and
in response to determining that the mechanical activity of the patient's heart does not represent the atrial contraction, deliver inhibited pacing to at least one of the ventricles of the patient's heart in the single-chamber sensing mode.

### Claim 20 (depends on 19)

The system of claim 19, wherein the first medical device comprises the controller.

### Claim 21 (depends on 19)

The system of claim 19, wherein the electrical activity of one or both atria of the patient's heart is based on a far-field measurement sensed by the at least one electrode of the second medical device.

### Claim 22 (depends on 19)

The system of claim 19, wherein first medical device is an intracardiac implantable medical device.

### Claim 23 (depends on 19)

The system of claim 19, wherein the first medical device is a leadless implantable device positioned in the left ventricle of the patient's heart.

### Claim 24 (depends on 19)

The system of claim 19, wherein the second medical device is a right-sided implantable device or an extravascular device.

### Claim 25 (depends on 19)

The system of claim 19, wherein the housing of the first medical device is implantable in the left ventricle (LV) of the patient's heart and the at least one electrode of the first medical device is implantable to deliver cardiac therapy to or sense electrical activity of the LV, wherein the second medical device comprises an extravascular housing.

### Claim 26 (depends on 19)

The system of claim 19, wherein the second medical device is operably coupled to communicate an atrial activation time to the first medical device to deliver pacing from the first medical device based on the atrial activation time.
